Noteworthy Cases

We periodically identify securities cases that we believe are appropriate for institutional leadership. These cases involve allegations of serious misrepresentations or concealed information about a company's business operations and prospects that have caused substantial losses for investors. When appropriate, we list these cases here and strongly recommend that institutional investors consider seeking to lead the prosecution of these cases. For more information about any of these cases, please send an email to BR&B partner Leslie Bornstein Molder.

Company Relevant Dates CUSIP NO.
ChemoCentryx, Inc.
NASDAQ: CCXI
Class Period:
November 26, 2019-May 3, 2021
Lead Motion Due: July 6, 2021
16383L106
Credit Suisse Group AG
NYSE: CS
Class Period:
October 29, 2020-March 31, 2021
Lead Motion Due: June 15, 2021
225401108
FibroGen, Inc.
NASDAQ: FGEN
Class Period:
November 8, 2019-April 6, 2021
Lead Motion Due: June 11, 2021
31572Q808
Canoo, Inc.
NASDAQ: GOEV; GOEVW
Class Period:
August 18, 2020-March 29, 2021
Lead Motion Due: June 1, 2021
13803R102; 13803R110
Lordstown Motors Corp.
NASDAQ: RIDE
Class Period:
August 3, 2020-March 17, 2021
Lead Motion Due: May 17, 2021
54405Q100
CytoDyn, Inc.
NASDAQ: OTC: CYDY
Class Period:
March 27, 2020-March 9, 2021
Lead Motion Due: May 17, 2021
23283M101